HbA1c表达水平判断中老年人脑卒中患者疗效的临床价值

The relation between the levels of glycolated hemoglobin and middle-aged and elderly stroke

目的:探讨糖化血红蛋白(HbA1c)表达水平对判断中老年人脑卒中患者预后的临床价值。方法:对2013年12月至2015年12月在笔者所在医院就诊的脑卒中患者196例进行回顾性分析研究,根据诊断患者HbA1c值的不同将其分为A、B、C 3组,各组患者HbA1c值分别为<155 mg·dl^(-1),155~199 mg·dl^(-1),>199 mg·dl^(-1)。对各病例的预后及疗效进行分析比较。结果:B、C组患者的NIHSS评分、Rankin评分、发展性卒中例数、住院天数及死亡率与A组相比均偏高,且差异有统计学意义(P<0.05)。结论:HbA1c升高的患者其发展性卒中例数及死亡率高,住院天数延长,对患者生活质量带来极大危害,应在临床上加以重视。

Objective： To explore the relation between the levels of glycolated hemoglobin and the prognosis of middle-aged and elderly stroke. Methods： 196 patients with stroke who were admitted to our hospital from December 2013 to December 2015 were retrospectively analyzed and researched. According to the levels of HbAlc,the 196 patients with stroke were divided into three groups： the HbAlc value of group A was below 155 mg·dl^-1,the HbAlc value of group B was from 155 mg·dl^-1 to 199 mg·dl^-1,the HbAlc value of group C was higher than199 mg·dl^（-1）. The prognosis and clinical efficacy of patients were analyzed and compared. Results： The NIHSS score,Rankin score,stroke cases,hospitalization days and mortality rates of group B and group C were higher than those of group A（ P〈0. 05）. Conclusion： The patients with high value of HbAlc have a high rate of being stroke and a long hospitalization days,which do great harm to patients＇ life quality and needs to be concerned.